SS05.1 IHPBA Meets SSAT: Contemporary Approaches to Borderline Resectable Pancreatic Cancer

SS05.1 IHPBA Meets SSAT: Contemporary Approaches to Borderline Resectable Pancreatic Cancer

Neoadjuvant Therapy: Why, What, When, How? W. Scott Helton - USA

Corporate Partners

Ethicon logo
Angiodynamics logo
Sirtex logo

If you are interested in becoming a Corporate Partner of the IHBPA please contact industry@ihpba.org

Find out more